US 9840549
Fusion polypeptides capable of activating receptors
granted A61PA61P17/02A61P3/10
Quick answer
US patent 9840549 (Fusion polypeptides capable of activating receptors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61P, A61P17/02, A61P3/10, A61P9/10